SUBSCRIBE
SUBSCRIBE

Sangamo Therapeutics, Inc.

NEWS
Genetown
Down Syndrome’s Extra Chromosome Silenced, University of Massachusetts Medical School, Sangamo BioSciences, Inc. Study
July 18, 2013
 · 
5 min read
Drug Development
Double Whammy Gene Therapy Clears HIV From Body, Sangamo BioSciences, Inc. Reveals
September 23, 2011
 · 
1 min read
Drug Development
New AIDS Approach Disrupts Patient’s DNA, Sangamo BioSciences, Inc. Announces
February 3, 2009
 · 
1 min read
Biotech Beach
The Week In Review: Biotech Treks Higher
February 5, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Deals Dominate Biotech News
December 12, 2006
 · 
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Diabetes News Rules
June 13, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Another Biotech
April 7, 2006
 · 
1 min read
Biotech Beach
Sangamo BioSciences, Inc. Reports Success Using ZNPs To Fight Aids
December 19, 2005
 · 
1 min read
Load More
AWARDS
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results
May 14, 2026
 · 
14 min read
Press Releases
Sangamo Therapeutics Announces First Quarter 2026 Earnings Call
May 11, 2026
 · 
1 min read
Press Releases
Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT)
April 30, 2026
 · 
4 min read
Press Releases
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
April 29, 2026
 · 
4 min read
Press Releases
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
March 30, 2026
 · 
17 min read
Press Releases
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
March 20, 2026
 · 
1 min read
Press Releases
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
March 9, 2026
 · 
6 min read
Press Releases
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026
February 4, 2026
 · 
10 min read
Press Releases
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering
February 4, 2026
 · 
4 min read
Press Releases
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
December 19, 2025
 · 
6 min read
Load More